KLIFO
Rasmus Nelund is an accomplished executive in the life sciences sector, currently serving as Chief Executive Officer at KLIFO since May 2023. Prior to this role, Rasmus held progressive leadership positions at NNIT from 2012 to 2023, including Corporate Vice President overseeing the Global Life Sciences segment where significant growth was achieved, with an average annual revenue increase of 16% since 2014. Rasmus has a strong track record in strategic management, M&A, and customer engagement, leading successful acquisitions that bolstered NNIT’s global operations. Earlier in Rasmus's career, notable roles included founder and CEO of CPI Advice, project director at Herax Methods A/S, and CEO of Pipeline Biotech, alongside academic contributions as an external associate professor at Copenhagen Business School. Rasmus Nelund holds an M.Sc. from Copenhagen Business School and various certifications in IT architecture and project management.
This person is not in any teams
KLIFO
KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark, Sweden, Germany and The Netherlands and employs more than 150 highly skilled employees.